RE:RE:Cold chain newsSome thoughts on the cold chain results. Obviously everyone wanted to see 100% success across the 3 serotypes, but the results are very encouraging. To get 100% success for the 2nd serotype on the 1st attempt is impressive given the uncertainty of R&D. Also, I am not an expert, but given the 30 degree success, I suspect serotypes 1&3 require something between a tweek and a modification, rather than a complete process redesign.
Another point is that even if this IPV test was 100% successful, this would not solve ALL of cold chain. IPV is a category C in terms of difficulty to break cold chain (which is mid range). MVMD would still have to prove out Category A&B samples to claim ALL of cold chain. Likely they would need some process changes anyway to achieve this. A good question for Dennis would be is this part of the 2 year agreement with the FDA?